GeneMatrix Promotes Sex and Respiratory Infection Testing Products at MEDLAB
|
By LabMedica International staff writers Posted on 06 Feb 2020 |
|
Illustration
GeneMatrix (Seoul, South Korea) promoted its main NeoPlex family of sex and respiratory infection testing products, at MEDLAB Middle East, which took place from 3-6 February 2020 at the Dubai World Trade Centre. MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, drew over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries.
GeneMatrix focuses on leading the personalized medicine business through the development of competitive platforms and molecular diagnosis products. GeneMatrix’s proprietary RFMP platform technology can derive values from the genetic information of living creatures. The RFMP technology embodies unparalleled specifications for precision, sensitivity, digitalized quantitative analysis, multi-biomarker’s batch analysis and large quantity sample processing. The elements of biotechnology, nanotechnology and IT technology are organically fused in RFMP technology, and it is now being widely used. Its utilization will be extended to early diagnosis, prognosis determination, selection of therapeutic agent, treatment reaction monitoring for chronic intractable diseases including infectious, metabolic, neoplastic and genetic diseases.
At MEDLAB Middle East 2020, promoted sex and respiratory infection testing products of its main pipeline, NeoPlex, which are based om the company's original C-Tag technology. GeneMatrix offers multiple products in its respiratory testing line. In the respiratory virus panel line, it has developed NeoPlex RV-Panel A and NeoPlex RV-Panel B, while in the bacterial panel line it has developed NeoPlex RB-8.
GeneMatrix’s NeoPlex RV-Panel A is capable of collectively diagnosing 10 major respiratory viral pathogens, including influenza A/B, respiratory syncytial virus A/B, parainfluenza 1/2/3, and adenovirus, in a single test. Its NeoPlex RV-Panel B can simultaneously diagnose nine respiratory viruses, including coronavirus, enterovirus, and rhinovirus. GeneMatrix has completed the clinical trials of NeoPlex RV-Panel B which is ready for early market release.
Related Links:
GeneMatrix
 Test.jpg)
GeneMatrix focuses on leading the personalized medicine business through the development of competitive platforms and molecular diagnosis products. GeneMatrix’s proprietary RFMP platform technology can derive values from the genetic information of living creatures. The RFMP technology embodies unparalleled specifications for precision, sensitivity, digitalized quantitative analysis, multi-biomarker’s batch analysis and large quantity sample processing. The elements of biotechnology, nanotechnology and IT technology are organically fused in RFMP technology, and it is now being widely used. Its utilization will be extended to early diagnosis, prognosis determination, selection of therapeutic agent, treatment reaction monitoring for chronic intractable diseases including infectious, metabolic, neoplastic and genetic diseases.
At MEDLAB Middle East 2020, promoted sex and respiratory infection testing products of its main pipeline, NeoPlex, which are based om the company's original C-Tag technology. GeneMatrix offers multiple products in its respiratory testing line. In the respiratory virus panel line, it has developed NeoPlex RV-Panel A and NeoPlex RV-Panel B, while in the bacterial panel line it has developed NeoPlex RB-8.
GeneMatrix’s NeoPlex RV-Panel A is capable of collectively diagnosing 10 major respiratory viral pathogens, including influenza A/B, respiratory syncytial virus A/B, parainfluenza 1/2/3, and adenovirus, in a single test. Its NeoPlex RV-Panel B can simultaneously diagnose nine respiratory viruses, including coronavirus, enterovirus, and rhinovirus. GeneMatrix has completed the clinical trials of NeoPlex RV-Panel B which is ready for early market release.
Related Links:
GeneMatrix
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
QC Software Solution
Unity Interlaboratory Program
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System
Latest MEDLAB 2020 News
- Diagnostica Stago Displays STA Compact Max and STA Satellite Max Analyzers at MEDLAB
- DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020
- Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020
- New Technology that Detects MRSA in 15 Minutes Introduced at MEDLAB Middle East 2020
- Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB
- Randox Showcases New All-In-One Solution for Molecular Diagnostics at MEDLAB Middle East 2020
- EKF Diagnostics Displays POC Analyzers for Hemoglobin, HbA1c And Lactate at MEDLAB Middle East
- Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020
- MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Portable Blood-Based Device Detects Colon Cancer
Colon cancer is the second leading cause of cancer-related deaths in the U.S., yet it is highly treatable when detected at an early stage. Traditional colonoscopy screenings, although effective, are unpleasant,... Read more
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channel
Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more
Microbiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read more
Pathology
view channel
New Test Diagnoses High-Risk Childhood Brain Tumors
Medulloblastoma, which originates in the cerebellum, the rear part of the brain, is the most prevalent malignant brain tumor in children and is notoriously difficult to diagnose. Currently, identifying... Read more
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read more
Industry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more
